Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Last day of trading in Detsky Mir shares will be August 28

2/27/24 DSKY

Magnit will open more than 30 new fast food outlets

2/27/24 MGNT

Tatneft to build a pulp production facility

2/27/24 TATN

Novatek started construction of an LNG terminal in Kamchatka

2/27/24 NVTK

Henderson's sales were up 32% in January

2/27/24 HNFG

X5 Delivery opened the first own hub for couriers

2/27/24 X5

VK wants to buy the rights to show the Olympics in Paris

2/27/24 VKCO

VTB migrates to Astra Linux

2/27/24 ASTR

Samolet acquired Moscow-based bank Sistema

2/27/24 SMLT

Qiwi not sure it will get paid for Russian assets

2/27/24 QIWI